1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Cell-based Assays Market by Product, Applications, End User, & Region - Global Forecast to 2020

The global cell-based assays market is expected to reach USD 18,329.37 million by 2020 from USD 10,799.53 million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. The product segments included in this report are consumables, instruments, services and software. The consumables segment is further divided on the basis of type into reagents and assay kits, cell lines, micro plates. Reagents and assay kits segment is further divided into reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays. Cell lines segment is further classified into immortalized cell lines, primary cell lines and stem cell lines. On the basis of applications; the report is segmented into basic research, drug discovery, predictive toxicology, ADME studies and other applications. The drug discovery had the largest share of the cell-based assays market in 2015. The predictive toxicology is expected to be one of the fastest growing applications between 2015 and 2020.

The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global cell-based assays market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020.

The key driver for this market is increased R&D spending on research. Furthermore, growing benefits of cell-based assays over other methods, their increasing adoption in drug discovery, and advancements in automation and high-throughput techniques will aid market growth.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global cell-based assays market and its sub-segments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their cell-based assays product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each sub segment and the relative differences in the growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important sub segments. It maps the market sizes and growth rates of each sub segment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the cell-based assays market. The competitive landscape covers the growth strategies adopted by the industry players over the last four years. It also includes analysis of industry developments like new product launches, expansions, agreements and collaborations and acquisitions.



Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.



The report provides insights on the following:
- Product Development: Product portfolios of the top players in the cell-based assays market.
- Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the cell-based assays market.
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various cell-based assays products across geographies.

Table Of Contents

Cell-based Assays Market by Product, Applications, End User, and Region - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.3 MARKET SHARE ESTIMATION 24
2.3.1 KEY DATA FROM SECONDARY SOURCES 24
2.3.2 KEY DATA FROM PRIMARY SOURCES 24
2.3.3 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 32
4.1 LUCRATIVE OPPORTUNITIES IN THE CELL-BASED ASSAYS MARKET 32
4.2 LIFE CYCLE ANALYSIS, BY REGION 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.1.1 BY PRODUCT 37
5.1.2 BY APPLICATION 38
5.1.3 BY END USER 38
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Increase in RandD investments 40
5.2.1.2 Government funding and public-private partnerships supporting cell-based research activities 40
5.2.1.3 Advantages of cell-based assays over prevalent technologies 41
5.2.1.4 Drug discovery, a major driver for the cell-based assays market 41

5.2.2 RESTRAINTS 42
5.2.2.1 High instrument costs 42
5.2.2.2 Stringent regulatory policies 42
5.2.2.3 Intellectual property rights issues restricting innovations in the market 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Asian region offers high-growth opportunities 43
5.2.3.2 Developments in high-content screening and software to transform cell-based screening 44
5.2.4 TRENDS 45
5.2.4.1 Label-free technologies are set to transform the market 45
6 CELL-BASED ASSAYS MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 CONSUMABLES 49
6.2.1 REAGENTS and ASSAY KITS 51
6.2.1.1 Reporter gene assays 53
6.2.1.2 Second messenger assays 54
6.2.1.3 Cell growth assays 55
6.2.1.4 Cell death assays 56
6.2.1.5 Other assays 57
6.2.2 MICROPLATES 58
6.2.3 CELL LINES 59
6.2.3.1 Immortalized cell lines 60
6.2.3.2 Primary cell lines 61
6.2.3.3 Stem cell lines 62
6.2.4 OTHER CONSUMABLES 63
6.3 INSTRUMENTS 64
6.4 SERVICES 66
6.5 SOFTWARE 68
7 CELL-BASED ASSAYS MARKET, BY APPLICATION 70
7.1 INTRODUCTION 71
7.2 DRUG DISCOVERY 72
7.3 BASIC RESEARCH 74
7.4 ADME STUDIES 75
7.5 PREDICTIVE TOXICOLOGY 77
7.6 OTHER APPLICATIONS 78

8 CELL-BASED ASSAYS MARKET, BY END USER 80
8.1 INTRODUCTION 81
8.2 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES 82
8.3 ACADEMIC and GOVERNMENT INSTITUTIONS 84
8.4 CONTRACT RESEARCH ORGANIZATIONS 85
8.5 OTHER END USERS 87
9 CELL-BASED ASSAYS MARKET, BY REGION 89
9.1 INTRODUCTION 90
9.2 NORTH AMERICA 93
9.2.1 U.S. 101
9.2.2 CANADA 106
9.3 EUROPE 112
9.4 ASIA 117
9.5 REST OF THE WORLD (ROW) 124
10 COMPETITIVE LANDSCAPE 130
10.1 INTRODUCTION 130
10.2 STRATEGIC OVERVIEW 130
10.3 MARKET SHARE ANALYSIS 131
10.4 COMPETITIVE SITUATION AND TRENDS 132
10.4.1 NEW PRODUCT LAUNCHES 133
10.4.2 ACQUISITIONS 134
10.4.3 COLLABORATIONS AND AGREEMENTS 135
10.4.4 EXPANSIONS 136
10.4.5 OTHER DEVELOPMENTS 136
11 COMPANY PROFILES 137
(Overview, Products and Services, Financials, Strategy and Development)*
11.1 INTRODUCTION 137
11.2 BECTON, DICKINSON AND COMPANY 138
11.3 CELL SIGNALING TECHNOLOGY, INC. 142
11.4 CISBIO BIOASSAYS 144
11.5 DANAHER CORPORATION 148
11.6 DISCOVERX CORPORATION 152
11.7 GENERAL ELECTRIC COMPANY 154
11.8 MERCK KGAA 157
11.9 PERKINELMER, INC. 160

11.10 PROMEGA CORPORATION 164
11.11 THERMO FISHER SCIENTIFIC, INC. 166
*Details on Overview, Products and Services, Financials, Strategy and Development might not be Captured in case of Unlisted Companies.
12 APPENDIX 170
12.1 INSIGHTS OF INDUSTRY EXPERTS 170
12.2 DISCUSSION GUIDE 171
12.3 OTHER DEVELOPMENTS 174
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 175
12.5 AVAILABLE CUSTOMIZATIONS 177
12.6 RELATED REPORTS 178


LIST OF TABLES

TABLE 1 CELL-BASED ASSAYS MARKET SUMMARY 26
TABLE 2 INCREASING HEALTHCARE EXPENDITURE: THE PRIMARY DRIVER FOR
THE GROWTH OF THE CELL-BASED ASSAYS MARKET 41
TABLE 3 MARKET GROWTH RESTRAINED BY HIGH INSTRUMENT COSTS 43
TABLE 4 EMERGING ECONOMIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES 45
TABLE 5 LABEL-FREE TECHNOLOGIES ARE AN IMPORTANT MARKET TREND 45
TABLE 6 CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 48
TABLE 7 CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY REGION,
2013-2020 (USD MILLION) 50
TABLE 8 CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2013-2020 (USD MILLION) 51
TABLE 9 CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS and ASSAY KITS, BY REGION, 2013-2020 (USD MILLION) 52
TABLE 10 CELL-BASED ASSAYS MARKET FOR REAGENTS and ASSAY KITS, BY TYPE,
2013-2020 (USD MILLION) 53
TABLE 11 CELL-BASED ASSAYS MARKET SIZE FOR REPORTER GENE ASSAYS, BY REGION, 2013-2020 (USD MILLION) 54
TABLE 12 CELL-BASED ASSAYS MARKET SIZE FOR SECOND MESSENGER ASSAYS,
BY REGION, 2013-2020 (USD MILLION) 55
TABLE 13 CELL-BASED ASSAYS MARKET SIZE FOR CELL GROWTH ASSAYS, BY REGION, 2013-2020 (USD MILLION) 56
TABLE 14 CELL-BASED ASSAYS MARKET SIZE FOR CELL DEATH ASSAYS, BY REGION,
2013-2020 (USD MILLION) 57
TABLE 15 CELL-BASED ASSAYS MARKET SIZE FOR OTHER ASSAYS, BY REGION,
2013-2020 (USD MILLION) 58
TABLE 16 CELL-BASED ASSAYS MARKET SIZE FOR MICROPLATES, BY REGION,
2013-2020 (USD MILLION) 59
TABLE 17 CELL-BASED ASSAYS MARKET SIZE FOR CELL LINES, BY REGION,
2013-2020 (USD MILLION) 60
TABLE 18 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE,
2013-2020 (USD MILLION) 60
TABLE 19 CELL-BASED ASSAYS MARKET SIZE FOR IMMORTALIZED CELL LINES, BY REGION, 2013-2020 (USD MILLION) 61
TABLE 20 CELL-BASED ASSAYS MARKET SIZE FOR PRIMARY CELL LINES, BY REGION,
2013-2020 (USD MILLION) 62
TABLE 21 CELL-BASED ASSAYS MARKET SIZE FOR STEM CELL LINES, BY REGION,
2013-2020 (USD MILLION) 63
TABLE 22 CELL-BASED ASSAYS MARKET SIZE FOR OTHER CONSUMABLES, BY REGION, 2013-2020 (USD MILLION) 64
TABLE 23 CELL-BASED ASSAYS MARKET SIZE FOR INSTRUMENTS, BY REGION,
2013-2020 (USD MILLION) 65
TABLE 24 CELL-BASED ASSAYS MARKET SIZE FOR SERVICES, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 25 CELL-BASED ASSAYS MARKET SIZE FOR SOFTWARE, BY REGION,
2013-2020 (USD MILLION) 69
TABLE 26 CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 72
TABLE 27 CELL-BASED ASSAYS MARKET SIZE FOR DRUG DISCOVERY APPLICATION,
BY REGION, 2013-2020 (USD MILLION) 73
TABLE 28 CELL-BASED ASSAYS MARKET SIZE FOR BASIC RESEARCH APPLICATION,
BY REGION, 2013-2020 (USD MILLION) 75
TABLE 29 CELL-BASED ASSAYS MARKET SIZE FOR ADME STUDIES APPLICATION, BY REGION, 2013-2020 (USD MILLION) 76
TABLE 30 CELL-BASED ASSAYS MARKET SIZE FOR PREDICTIVE TOXICOLOGY APPLICATION, BY REGION, 2013-2020 (USD MILLION) 78
TABLE 31 CELL-BASED ASSAYS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION,
2013-2020 (USD MILLION) 79
TABLE 32 CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 82
TABLE 33 CELL-BASED ASSAYS MARKET SIZE FOR PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION) 83
TABLE 34 CELL-BASED ASSAYS MARKET SIZE FOR ACADEMIC and GOVERNMENT INSTITUTIONS, BY REGION, 2013-2020 (USD MILLION) 85
TABLE 35 CELL-BASED ASSAYS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013-2020 (USD MILLION) 86
TABLE 36 CELL-BASED ASSAYS MARKET SIZE FOR OTHER END USERS, BY REGION,
2013-2020 (USD MILLION) 88
TABLE 37 CELL-BASED ASSAYS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 92
TABLE 38 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 95
TABLE 39 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 96
TABLE 40 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 97
TABLE 41 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS
and ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION) 98
TABLE 42 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 99
TABLE 43 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 100
TABLE 44 U.S.: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 102
TABLE 45 U.S.: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2013-2020 (USD MILLION) 103
TABLE 46 U.S.: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS and ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION) 104
TABLE 47 U.S.: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 105
TABLE 48 U.S.: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 106
TABLE 49 CANADA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 107
TABLE 50 CANADA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2013-2020 (USD MILLION) 108
TABLE 51 CANADA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS and ASSAY KITS,
BY TYPE, 2013-2020 (USD MILLION) 109
TABLE 52 CANADA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 110
TABLE 53 CANADA: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 111
TABLE 54 EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 113
TABLE 55 EUROPE: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 114
TABLE 56 EUROPE: CELL-BASED ASSAYS MARKET FOR REAGENTS and ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION) 115
TABLE 57 EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 116
TABLE 58 EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 117
TABLE 59 ASIA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 119
TABLE 60 ASIA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2013-2020 (USD MILLION) 120
TABLE 61 ASIA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS and ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION) 121
TABLE 62 ASIA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 122
TABLE 63 ASIA: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 123
TABLE 64 ROW: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 125
TABLE 65 ROW: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2013-2020 (USD MILLION) 126
TABLE 66 ROW: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS and ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION) 127
TABLE 67 ROW: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 128
TABLE 68 ROW: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 129
TABLE 69 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND SEPTEMBER 2015 133
TABLE 70 NEW PRODUCT LAUNCHES, JAUNARY 2013 TO SEPTEMBER 2015 133
TABLE 71 ACQUISITIONS, JAUNARY 2013 TO SEPTEMBER 2015 134
TABLE 72 COLLABORATIONS AND AGREEMENTS, JAUNARY 2013 TO SEPTEMBER 2015 135
TABLE 73 EXPANSIONS, JAUNARY 2013 TO SEPTEMBER 2015 136
TABLE 74 OTHER DEVELOPMENTS, JAUNARY 2013 TO SEPTEMBER 2015 136


LIST OF FIGURES

FIGURE 1 CELL-BASED ASSAYS MARKET 17
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 6 DATA TRIANGULATION METHODOLOGY 23
FIGURE 7 CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 27
FIGURE 8 CONSUMABLES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 28
FIGURE 9 REAGENTS and KITS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 28
FIGURE 10 CELL LINES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 29
FIGURE 11 CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
2015 VS. 2020 (USD MILLION) 29
FIGURE 12 CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 30
FIGURE 13 CELL-BASED ASSAYS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 31
FIGURE 14 GLOBAL CELL-BASED ASSAYS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 32
FIGURE 15 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES END-USER SEGMENT TO DOMINATE THE CELL-BASED ASSAYS MARKET 33
FIGURE 16 ASIA TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 34
FIGURE 17 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 35
FIGURE 18 CELL-BASED ASSAYS MARKET SEGMENTATION: BY PRODUCT 37
FIGURE 19 CELL-BASED ASSAYS MARKET SEGMENTATION: BY APPLICATION 38
FIGURE 20 CELL-BASED ASSAYS MARKET SEGMENTATION: BY END USER 38
FIGURE 21 INCREASING RandD SPENDING WILL DRIVE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD 39
FIGURE 22 INCREASING RandD INVESTMENTS BOOSTING GROWTH IN
THE CELL-BASED ASSAYS MARKET 44
FIGURE 23 CELL-BASED ASSAYS MARKET SEGMENTATION, BY PRODUCT 47
FIGURE 24 CELL-BASED ASSAYS MARKET, BY PRODUCT, 2015 (USD MILLION) 48
FIGURE 25 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF
THE CONSUMABLES MARKET IN 2015 49
FIGURE 26 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE,
2015 VS. 2020 (USD MILLION) 50
FIGURE 27 CELL-BASED ASSAYS MARKET FOR REAGENTS and ASSAY KITS, BY TYPE,
2015 VS. 2020 (USD MILLION) 52
FIGURE 28 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE INSTRUMENTS MARKET IN 2015 65
FIGURE 29 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE SERVICES MARKET IN 2015 67
FIGURE 30 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF
THE SOFTWARE MARKET IN 2015 68
FIGURE 31 CELL-BASED ASSAYS MARKET SEGMENTATION, BY APPLICATION 71
FIGURE 32 DRUG DISCOVERY ACCOUNTS FOR THE LARGEST APPLICATION SEGMENT OF
THE CELL-BASED ASSAYS MARKET IN 2015 71
FIGURE 33 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
THE DRUG DISCOVERY APPLICATION SEGMENT IN 2015 73
FIGURE 34 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATION IN 2015 74
FIGURE 35 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
THE ADME STUDIES APPLICATION SEGMENT IN 2015 76
FIGURE 36 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
THE PREDICTIVE TOXICOLOGY APPLICATION SEGMENT IN 2015 77
FIGURE 37 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
THE OTHER APPLICATIONS SEGMENT IN 2015 79
FIGURE 38 CELL-BASED ASSAYS MARKET SEGMENTATION, BY END USER 81
FIGURE 39 CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015 (USD MILLION) 81
FIGURE 40 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES IN 2015 83
FIGURE 41 CELL-BASED ASSAYS MARKET FOR ACADEMIC and GOVERNMENT INSTITUTIONS TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2015 AND 2020 84
FIGURE 42 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020 86
FIGURE 43 CELL-BASED ASSAYS MARKET FOR OTHER END USERS TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2015 AND 2020 87
FIGURE 44 ASIA TO GROW AT THE HIGHEST RATE IN THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD 91
FIGURE 45 GEOGRAPHIC SNAPSHOT (2015) 92
FIGURE 46 NORTH AMERICA: MARKET SNAPSHOT 94
FIGURE 47 THE U.S. IS ESTIMATED TO DOMINATE THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2015 95
FIGURE 48 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2015 96
FIGURE 49 REAGENTS and ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE NORTH AMERICAN CONSUMABLES MARKET IN 2015 97
FIGURE 50 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE NORTH AMERICAN REAGENTS and ASSAY KITS MARKET IN 2015 98
FIGURE 51 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
THE APPLICATION MARKET IN NORTH AMERICA IN 2015 99
FIGURE 52 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
THE LARGEST SHARE OF THE END-USER MARKET IN NORTH AMERICA 100
FIGURE 53 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
THE U.S. CELL-BASED ASSAYS MARKET IN 2015 101
FIGURE 54 REAGENTS and ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE U.S. CONSUMABLES MARKET IN 2015 102
FIGURE 55 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE U.S. REAGENTS and ASSAY KITS MARKET IN 2015 103
FIGURE 56 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF
THE U.S. CELL-BASED ASSAYS MARKET IN 2015 104
FIGURE 57 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
THE LARGEST SHARE OF THE END-USER MARKET IN THE U.S. 105
FIGURE 58 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
THE CELL-BASED ASSAYS MARKET IN CANADA IN 2015 107
FIGURE 59 REAGENTS and ASSAYS KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE CONSUMABLES MARKET IN CANADA IN 2015 108
FIGURE 60 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE REAGENTS and ASSAY KITS MARKET IN CANADA IN 2015 109
FIGURE 61 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF
THE CELL-BASED ASSAYS MARKET IN CANADA IN 2015 110
FIGURE 62 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
THE LARGEST SHARE OF THE END-USER MARKET IN CANADA 111
FIGURE 63 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
THE EUROPEAN CELL-BASED ASSAYS MARKET IN 2015 112
FIGURE 64 REAGENTS and ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE EUROPEAN CONSUMABLES MARKET IN 2015 113
FIGURE 65 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE EUROPEAN REAGENTS and ASSAY KITS MARKET IN 2015 114
FIGURE 66 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
THE CELL-BASED ASSAYS APPLICATION MARKET IN EUROPE IN 2015 115
FIGURE 67 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
THE LARGEST SHARE OF THE CELL-BASED ASSAYS END-USER MARKET IN EUROPE 116
FIGURE 68 ASIA: MARKET SNAPSHOT 118
FIGURE 69 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
THE ASIAN MARKET IN 2015 119
FIGURE 70 REAGENTS and ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE ASIAN CONSUMABLES MARKET IN 2015 120
FIGURE 71 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE ASIAN REAGENTS and ASSAY KITS MARKET IN 2015 121
FIGURE 72 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
THE CELL-BASED ASSAYS APPLICATIONS MARKET IN ASIA IN 2015 122
FIGURE 73 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
THE LARGEST SHARE OF THE CELL-BASED ASSAYS END-USER MARKET IN ASIA 123
FIGURE 74 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
THE ROW CELL-BASED ASSAYS MARKET IN 2015 124
FIGURE 75 REAGENTS and ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE ROW CONSUMABLES MARKET IN 2015 125
FIGURE 76 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
THE ROW REAGENTS and ASSAY KITS MARKET IN 2015 126
FIGURE 77 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
THE ROW CELL-BASED ASSAYS APPLICATIONS MARKET IN 2015 127
FIGURE 78 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
THE LARGEST SHARE OF THE ROW CELL-BASED ASSAYS END-USER MARKET 128
FIGURE 79 NEW PRODUCTS LAUNCHES IS THE KEY GROWTH STRATEGY ADOPTED
BY PLAYERS IN THE CELL-BASED ASSAYS MARKET 130
FIGURE 80 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 131
FIGURE 81 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS 137
FIGURE 82 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 138
FIGURE 83 DANAHER CORPORATION: COMPANY SNAPSHOT 148
FIGURE 84 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 154
FIGURE 85 MERCK KGAA: COMPANY SNAPSHOT 157
FIGURE 86 PERKINELMER, INC.: COMPANY SNAPSHOT 160
FIGURE 87 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 166

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

Life Science Instrumentation Market by Technology, End User, Application - Global Forecast to 2021

Life Science Instrumentation Market by Technology, End User, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global life science instrumentation market is estimated to grow at a CAGR of 6.8% from 2016 to 2021, to reach USD 64.52 billion by 2021. Factors such as increasing spending on pharmaceutical R&D, growing ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.